Literature DB >> 21763655

The relationship between resting heart rate and incidence and progression of coronary artery calcification: the Multi-Ethnic Study of Atherosclerosis (MESA).

Jonathan Rubin1, Michael J Blaha, Matthew J Budoff, Juan J Rivera, Leslee J Shaw, Ron Blankstein, Mouaz-Al Mallah, J Jeffrey Carr, Donald-Lloyd Jones, Roger S Blumenthal, Khurram Nasir.   

Abstract

OBJECTIVE: Elevated resting heart rate has been independently associated with cardiovascular and all-cause mortality. The pathophysiological mechanisms by which this increased risk occurs are unclear. We hypothesized that elevated resting heart rate will be associated with increased development of atherosclerosis, as assessed by the incidence and progression of coronary artery calcium (CAC).
METHODS: The Multi-Ethnic Study of Atherosclerosis is a prospective cohort study of participants free of clinical cardiovascular disease at entry. Among persons without CAC at baseline, the association between increasing clinical categories of heart rate (<60, 61-70, 71-80, >80bpm) and CAC incidence was assessed by relative risk regression after adjusting for covariates. Among those with detectable CAC at baseline, progression of CAC was assessed using multivariable robust linear regression.
RESULTS: Our study population consisted of 6004 individuals (62±10 years, 48% males). Among 3079 individuals with no detectable CAC at baseline, 20% (n=620) developed CAC. After adjusting for CVD risk factors, participants with a baseline resting heart rate >80bpm had an increased risk of incident CAC as compared to those with a resting heart rate <60 (relative risk=1.65, 95% CI=1.02, 2.66). Among persons with CAC present at baseline, participants with a baseline resting heart rate >80bpm had greater CAC score progression than those with a resting heart rate <60 (β=17.10; 95% CI=4.29, 29.85).
CONCLUSION: Elevated resting heart rate, a well-described predictor of cardiovascular mortality with unclear mechanism, is associated with increased incidence and progression of coronary atherosclerosis among individuals free of CVD at baseline.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21763655     DOI: 10.1016/j.atherosclerosis.2011.06.033

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  10 in total

1.  Associations between elevated resting heart rate and subclinical atherosclerosis in asymptomatic Korean adults undergoing coronary artery calcium scoring.

Authors:  Donghee Han; Ji Hyun Lee; Asim Rizvi; Lohendran Baskaran; Hyo Eun Park; Su-Yeon Choi; Eun Ju Chun; Jidong Sung; Sung Hak Park; Hae-Won Han; James K Min; Hyuk-Jae Chang; Bríain Ó Hartaigh
Journal:  Int J Cardiovasc Imaging       Date:  2016-07-21       Impact factor: 2.357

2.  Association of resting heart rate with carotid and aortic arterial stiffness: multi-ethnic study of atherosclerosis.

Authors:  Seamus P Whelton; Ron Blankstein; Mouaz H Al-Mallah; Joao A C Lima; David A Bluemke; W Gregory Hundley; Joseph F Polak; Roger S Blumenthal; Khurram Nasir; Michael J Blaha
Journal:  Hypertension       Date:  2013-07-08       Impact factor: 10.190

3.  Resting heart rate and the incidence and progression of valvular calcium: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Kojo Amoakwa; Oluwaseun E Fashanu; Martin Tibuakuu; Di Zhao; Eliseo Guallar; Seamus P Whelton; Wesley T O'Neal; Wendy S Post; Matthew J Budoff; Erin D Michos
Journal:  Atherosclerosis       Date:  2018-04-06       Impact factor: 5.162

4.  Ideal cardiovascular health and resting heart rate in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Olatokunbo Osibogun; Oluseye Ogunmoroti; Erica S Spatz; Oluwaseun E Fashanu; Erin D Michos
Journal:  Prev Med       Date:  2019-11-09       Impact factor: 4.018

Review 5.  How Heart Rate Should Be Controlled in Patients with Atherosclerosis and Heart Failure.

Authors:  Rose Mary Ferreira Lisboa da Silva; Anaisa Silva Roever Borges; Nilson Penha Silva; Elmiro Santos Resende; Gary Tse; Tong Liu; Leonardo Roever; Giuseppe Biondi-Zoccai
Journal:  Curr Atheroscler Rep       Date:  2018-09-17       Impact factor: 5.113

6.  Predictors for progressions of brachial-ankle pulse wave velocity and carotid intima-media thickness over a 12-year follow-up: Hanzhong Adolescent Hypertension Study.

Authors:  Yang Wang; Yue Yuan; Wei-Hua Gao; Yu Yan; Ke-Ke Wang; Peng-Fei Qu; Jia-Wen Hu; Chao Chu; Li-Jun Wang; Ke Gao; Yue-Yuan Liao; Chen Chen; Jing-Tao Xu; Qiong Ma; Wen-Ling Zheng; Hao Li; Zu-Yi Yuan; Jian-Jun Mu
Journal:  J Hypertens       Date:  2019-06       Impact factor: 4.844

7.  Effects of selective heart rate reduction with ivabradine on LV function and central hemodynamics in patients with chronic coronary syndrome.

Authors:  Anna Lena Hohneck; Peter Fries; Jonas Stroeder; Günther Schneider; Stephan Henrik Schirmer; Jan-Christian Reil; Michael Böhm; Ulrich Laufs; Florian Custodis
Journal:  Int J Cardiol Heart Vasc       Date:  2021-03-23

8.  Heart Rate and Heart Rate Variability Changes Are Not Related to Future Cardiovascular Disease and Death in People With and Without Dysglycemia: A Downfall of Risk Markers? The Whitehall II Cohort Study.

Authors:  Christian S Hansen; Marit E Jørgensen; Marek Malik; Daniel R Witte; Eric J Brunner; Adam G Tabák; Mika Kivimäki; Dorte Vistisen
Journal:  Diabetes Care       Date:  2021-02-01       Impact factor: 19.112

9.  Association of resting heart rate with cardiovascular function: a cross-sectional study in 522 Finnish subjects.

Authors:  Jenni K Koskela; Anna Tahvanainen; Antti Haring; Antti J Tikkakoski; Erkki Ilveskoski; Jani Viitala; Miia H Leskinen; Terho Lehtimäki; Mika Ap Kähönen; Tiit Kööbi; Onni Niemelä; Jukka T Mustonen; Ilkka H Pörsti
Journal:  BMC Cardiovasc Disord       Date:  2013-11-15       Impact factor: 2.298

10.  Long-term cardiovascular risks associated with an elevated heart rate: the Framingham Heart Study.

Authors:  Jennifer E Ho; Martin G Larson; Anahita Ghorbani; Susan Cheng; Erin E Coglianese; Ramachandran S Vasan; Thomas J Wang
Journal:  J Am Heart Assoc       Date:  2014-05-08       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.